Remdesivir, the antiviral drug from Gilead Sciences that may be effective in the treatment of Covid-19, was made available to Korean patients starting Wednesday. Injections will be approved for 33 patients with severe symptoms in Korea.
Remdesivir, the antiviral drug from Gilead Sciences that may be effective in the treatment of Covid-19, will be available to Korean hospitals starting today, said the Korea Centers for Disease Control and Prevention (KCDC).
Remdesivir, the antiviral drug that may be effective in the treatment of Covid-19, has been approved for emergency use by the Ministry of Food and Drug Safety. Details on when and how much of the drug will land in the country have yet to be decided.
Korea is seeking to import remdesivir as an emergency treatment for coronavirus patients, based on recommendations by local experts and clinical tests, health officials said Friday.
While various antiviral drugs are being tested for Covid-19 treatment, remdesivir has become the first scientifically proven effective treatment for the new coronavirus.
Korea is considering importing Gilead Sciences’ remdesivir as a coronavirus treatment after the experimental Ebola antiviral drug earned approval for emergency use from the United States.